Skip to content

SOP 22.041

  • 1 min read

ASEPTIC PREPARATION OF GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.040

  • 1 min read

SAFE HANDLING OF SPILLAGE, PERSONAL CONTAMINATION OR INJURY INVOLVING GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.039

  • 1 min read

CLEANING THE ASEPTIC ROOM AND ISOLATOR USED TO PREPARE GENETICALLY MODIFIED ORGANISM PRODUCTS (GMO)   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.038

  • 1 min read

INTRODUCTION TO GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS WITHIN CLINICAL TRIALS   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.037

  • 1 min read

Tracking and Release of IMPs placed into quarantine post delivery at pharmacy sites   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.035

  • 1 min read

Clinical Trial Information Provided to Site On-Call Pharmacists   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.034

  • 1 min read

Management of controlled drug IMPs within pharmacy sites   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.033

  • 1 min read

Incident reporting for pharmacy clinical trials   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.031

  • 1 min read

Role of pharmacy services in support of trials that are hosted by NHS GG&C: an overview   For Password contact Lead Pharmacist Clinical Trials R&I

SOP 22.030

  • 1 min read

Role of NHS GG&C pharmacy clinical trial services: an overview   For Password contact Lead Pharmacist Clinical Trials R&I